We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+6.57%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$49.1B
AUM Growth
+$4.31B
Cap. Flow
+$1.72B
Cap. Flow %
3.51%
Top 10 Hldgs %
14.46%
Holding
3,114
New
67
Increased
2,155
Reduced
468
Closed
57

Sector Composition

Rank Sector Weight
1 Financials 14.36%
2 Healthcare 13.62%
3 Technology 13.02%
4 Industrials 11.1%
5 Energy 9.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRM
2501
DELISTED
FURMANITE CORPORATION COM
FRM
$566K ﹤0.01%
56,700
MCHB
2502
Mechanics Bancorp
MCHB
$3.8B
$565K ﹤0.01%
29,411
+5,484
+23% +$114K
AOI
2503
DELISTED
Alliance One International
AOI
$564K ﹤0.01%
19,085
-3,754
-16% -$127K
VLGEA icon
2504
Village Super Market
VLGEA
$618M
$563K ﹤0.01%
14,750
-468
-3% -$17K
SCLN
2505
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
$563K ﹤0.01%
110,535
-1,583
-1% -$8.81K
ACHN
2506
DELISTED
Achillion Pharmaceuticals
ACHN
$559K ﹤0.01%
210,745
+21,649
+11% +$148K
ENZN
2507
DELISTED
ENZON PHARMACEUTICALS INC
ENZN
$557K ﹤0.01%
318,220
-91,580
-22% -$169K
LFVN icon
2508
LifeVantage
LFVN
$84M
$556K ﹤0.01%
34,178
-448
-1% -$7.74K
VHI icon
2509
Valhi
VHI
$463M
$556K ﹤0.01%
2,357
-127
-5% -$27K
GSIG
2510
DELISTED
GSI GROUP INC COM STK (CDA)
GSIG
$556K ﹤0.01%
58,016
-1,052
-2% -$9.13K
NDLS icon
2511
Noodles & Co
NDLS
$93M
$555K ﹤0.01%
+1,612
New +$561K
VASC
2512
DELISTED
Vascular Solutions Inc
VASC
$555K ﹤0.01%
33,367
+1,552
+5% +$25.1K
CTG
2513
DELISTED
Computer Task Group, Inc.
CTG
$553K ﹤0.01%
30,867
+1,552
+5% +$30.4K
PTLA
2514
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$550K ﹤0.01%
20,191
+873
+5% +$20.8K
PQUE
2515
DELISTED
PETROQUEST ENERGY INC (DE)
PQUE
$545K ﹤0.01%
136,161
-2,419
-2% -$9.68K
AMBA icon
2516
Ambarella
AMBA
$3.64B
$544K ﹤0.01%
26,400
GLOG
2517
DELISTED
GASLOG LTD
GLOG
$544K ﹤0.01%
36,400
TMHC
2518
DELISTED
Taylor Morrison
TMHC
$542K ﹤0.01%
23,847
-1,081
-4% -$24.4K
IIIN icon
2519
Insteel Industries
IIIN
$633M
$541K ﹤0.01%
33,219
-5,584
-14% -$93.9K
SPNT icon
2520
SiriusPoint
SPNT
$2.62B
$541K ﹤0.01%
+36,200
New +$488K
PTVCB
2521
DELISTED
Protective Insurance Corporation Class B Common Stock
PTVCB
$540K ﹤0.01%
21,250
+873
+4% +$21.8K
SFM icon
2522
Sprouts Farmers Market
SFM
$7.87B
$539K ﹤0.01%
+11,988
New +$476K
ENT
2523
DELISTED
Global Eagle Entertainment Inc.
ENT
$539K ﹤0.01%
2,314
+18
+0.8% +$4.48K
AIQ
2524
DELISTED
Alliance Healthcare Services
AIQ
$538K ﹤0.01%
+18,460
New +$400K
TRK
2525
DELISTED
Speedway Motorsports, Inc.
TRK
$537K ﹤0.01%
29,604
-742
-2% -$13.7K

Similar funds

Charles Schwab's Q3 2013 Portfolio in Review

As of Q3 2013, Charles Schwab held 3,114 positions worth $49.1B, up 9.6% from $44.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Charles Schwab deployed $1.72B of net new capital in Q3 2013, opening 67 new positions and adding to 2,155 existing holdings. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 4,003,512 shares worth $136M.

By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Merck, an estimated $76M trimmed.

  • Charles Schwab's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 4,003,512 shares worth $136M.
  • Charles Schwab added most to Johnson & Johnson in Q3 2013, an estimated $125M increase.
  • Charles Schwab's biggest Q3 2013 reduction was Merck, cutting an estimated $76M.
  • Charles Schwab fully exited SPRINT CORP FON COM in Q3 2013, selling an estimated $47.2M.
  • Charles Schwab's ten largest holdings make up 14% of its $49.1B portfolio in Q3 2013.
  • Charles Schwab opened 67 new positions and closed 57 in Q3 2013.
  • Charles Schwab's portfolio value rose 9.6% quarter-over-quarter to $49.1B.

Based on Charles Schwab's 13F filing for Q3 2013, filed 14 Nov 2013.